NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.06 (-3.06%)
Close on Nov 18, 2026Market cap $151.33MP/E –Yield –
NervGen Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
NervGen Pharma's market cap was $107.53M on Nov 11, 2026, against $301.03M a year earlier. Over the last 3 years it ranged from $85.24M to $393.87M, with a median of $152.13M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $107.53M | -72.7% |
| 2025 | Dec 31, 2025 | $393.87M | +203.1% |
| 2024 | Dec 31, 2024 | $129.94M | – |
See a number that looks wrong?